RxDoctor Payments Data

Rochelle Clark, PA

Medical · Urbana, OHNPI 1730467499

Payments from drug & device makers

$1,711in general payments, 2019–2025

Across 97 payments — averaging $17.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$358
  • Novo Nordisk$152
  • AstraZeneca$149
  • Astellas Pharma US Inc$147
  • Abbott$115
  • Exact Sciences$103
  • plus $686 from 12 others

What the payments were for

  • Food & beverage$1,711100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,711 in reported general payments places this provider in the 75th percentile of 547 medical providers in Ohio.

See all medical providers in Ohio

Medicare billing

Part B allowed, 2024
$47,689
Medicare patients
153
Services billed
1,012

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide74$94,816
RybelsusSemaglutide53$59,154
TrulicityDulaglutide35$56,322
JardianceEmpagliflozin62$46,980
MounjaroTirzepatide27$28,525
XareltoRivaroxaban26$27,513
EliquisApixaban41$23,183
JanuviaSitagliptin Phosphate18$21,319
Tresiba Flextouch U-100Insulin Degludec29$15,638
Atorvastatin Calcium420$3,530
Losartan Potassium286$2,657
Omeprazole201$2,046
Insulin Lispro Kwikpen U-100Insulin Lispro15$1,977
Pantoprazole Sodium150$1,905
Levemir FlexpenInsulin Detemir11$1,747

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$152$153,970127 claims
Lilly USA, LLCTrulicity, Mounjaro$88$84,84762 claims
PfizerEliquis$91$23,18341 claims
MerckJanuvia$20$21,31918 claims
AbbVieSynthroid$358$1,13640 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 547 medical providers in Ohio.

Other medical in Urbana

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →